CytoMed Therapeutics Limited (GDTC) Net margin 2024–2025
CytoMed Therapeutics Limited (GDTC) net profit margin by fiscal year — reported net income divided by reported revenue.
-1227.1%FY2025 · since FY2024: -3621.1% → -1227.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1227.1% | +2394.0 pp |
| FY2024 | -3621.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice